Report cover image

Prosthetic Joint Infection Market - A Global and Regional Analysis: Focus on Country and Regional Analysis - Analysis and Forecast, 2026-2036

Publisher BIS Research
Published Mar 16, 2026
SKU # BIS21007044

Description

Market Overview

The global prosthetic joint infection market remains an early-stage therapeutic arena with no prosthetic joint infection-specific drug approvals across major regulators. Current medical management relies on surgery (DAIR, two-stage revision) plus antibiotics; however, these agents are approved for broader infections rather than prosthetic joint infection itself and thus fall outside this scope. Market momentum is driven by rising arthroplasty volumes and a persistent prosthetic joint infection incidence of roughly 1–2% after joint replacement, underscoring a significant unmet need. Emerging pipelines target biofilm-embedded pathogens and staphylococcal dominance with novel mechanisms and regulator incentives.

Impact

Increasing demand for prosthetic joint infection therapies is anticipated to support the growth of the global prosthetic joint infection market during the forecast period 2025-2035.
The global prosthetic joint infection market is expected to grow at a significant rate due to advancements in treatment, the development of innovative therapies, and increasing drug approvals for the treatment of prosthetic joint infection.

Demand – Drivers and Limitations

The following are the drivers for the global prosthetic joint infection market:

Rising arthroplasty volumes and persistent prosthetic joint infection incidence (≈1–2%) expand the eligible population for prosthetic joint infection-specific therapeutics.
Biofilm-driven treatment failures create demand for novel mechanisms that penetrate biofilms and eradicate staphylococcal burdens.
Strong U.S. regulatory incentives (QIDP, Fast Track, Orphan) accelerate development timelines and attract capital for antibacterial innovation in prosthetic joint infection.

The global prosthetic joint infection market is expected to face some limitations, too, due to the following challenges:

Complex trial execution (surgical heterogeneity, microbiology mix, long follow-up) inflates cost and prolongs timelines.
Endpoint and access uncertainty—payers and HTAs will require robust evidence on revision avoidance, function, and durability to justify adoption.

How Can This Report Add Value to an Organization?

Product/Innovation Strategy:Pinpoint the highest-probability clinical settings (DAIR vs. staged revisions) and refine target product profiles for biofilm eradication, surgical compatibility, and rapid sterilization. Map regulatory advantages (QIDP/Fast Track/Orphan), critical endpoints, and KOL-validated trial designs. Benchmark emerging mechanisms (AMPs, FabI inhibition) to prioritize differentiated assets and inform CMC, delivery, and peri-operative integration strategies.

Competitive Strategy:Compare leading programs on mechanism, spectrum, biofilm activity, phase status, and regulatory incentives. Identify partnership opportunities with orthopedic networks and revision centers to accelerate enrollment and real-world evidence. Build payer narratives around fewer revisions, Length of stay reductions, and functional recovery. Use scenario planning to prepare for first-to-market dynamics and regional access hurdles.

*PDF email from publisher allows for 1-3 users, with permission to print*

Please Note: It will take 7-10 business days to complete the report upon order confirmation.

Table of Contents

Executive Summary
Scope and Definition
Market/Product Definition
Key Questions Answered
Analysis and Forecast Note
1. Global Prosthetic Joint Infection Market: Industry Outlook
1.1 Market Overview
1.2 Epidemiological Analysis
1.3 Clinical Trials
1.4 Regulatory Landscape / Compliance
1.5 Key Trends
1.6 Market Dynamics
1.6.1 Impact Analysis
1.6.2 Market Drivers
1.6.3 Market Restraints
1.6.4 Market Opportunities
2. Global Prosthetic Joint Infection Market, by Region, $Million, 2025-2036
2.1 North America
2.1.1 Market Dynamics
2.1.2 Market Sizing and Forecast
2.1.2.1 North America Prosthetic Joint Infection Market, by Country
2.1.2.1.1 U.S.
2.1.2.1.2 Canada
2.2 Europe
2.2.1 Market Dynamics
2.2.2 Market Sizing and Forecast
2.2.2.1 Europe Prosthetic Joint Infection Market, by Country
2.2.2.1.1 Germany
2.2.2.1.2 U.K.
2.2.2.1.3 France
2.2.2.1.4 Italy
2.2.2.1.5 Spain
2.2.2.1.6 Rest-of -Europe
2.3 Asia-Pacific
2.3.1 Market Dynamics
2.3.2 Market Sizing and Forecast
2.3.2.1 Asia-Pacific Prosthetic Joint Infection Market, by Country
2.3.2.1.1 Japan
2.3.2.1.2 Rest-of-Asia-Pacific
2.4 Rest-of-the-world
2.4.1 Market Dynamics
2.4.2 Market Sizing and Forecast
3. Global Prosthetic Joint Infection Market: Competitive Landscape and Company Profiles
3.1 Key Developments and Strategies
3.1.1 Funding Activities
3.1.2 Mergers and Acquisitions
3.1.3 Regulatory Approvals
3.1.4 Partnerships, Collaborations, and Business Expansions
3.2 Company Profiles
3.2.1 Avadel
3.2.1.1 Overview
3.2.1.2 Product Portfolio
3.2.1.3 Target Customers
3.2.1.4 Key Personnel
3.2.1.5 Analyst View
3.2.2 Wellesley Pharmaceuticals, LLC
3.2.2.1 Overview
3.2.2.2 Product Portfolio
3.2.2.3 Target Customers
3.2.2.4 Key Personnel
3.2.2.5 Analyst View
3.2.3 Ferring Pharmaceuticals
3.2.3.1 Overview
3.2.3.2 Product Portfolio
3.2.3.3 Target Customers
3.2.3.4 Key Personnel
3.2.3.5 Analyst View
3.2.4 Idorsia Pharmaceuticals Ltd.
3.2.4.1 Overview
3.2.4.2 Product Portfolio
3.2.4.3 Target Customers
3.2.4.4 Key Personnel
3.2.4.5 Analyst View
3.2.5 Others
4. Research Methodology
List of Figures
Figure: Prosthetic Joint Infection Market (by Scenario), $Million, 2025, 2030, and 2036
Figure: Global Prosthetic Joint Infection Market, 2025 and 2036
Figure: Global Prosthetic Joint Infection Market Key Trends, Impact Analysis
Figure: North America Prosthetic Joint Infection Market, $Million, 2025-2036
Figure: Europe Prosthetic Joint Infection Market, $Million, 2025-2036
Figure: Asia-Pacific Prosthetic Joint Infection Market, $Million, 2025-2036
Figure: Rest-of-the-World Prosthetic Joint Infection Market, $Million, 2025-2036
List of Tables
Table: Market Snapshot
Table: Market Dynamics
Table: Global Prosthetic Joint Infection Market (by Region), $Million, 2025-2036

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us